Φορτώνει......
Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells
Since about 70% of commercial biopharmaceutical products have been produced in Chinese hamster ovary (CHO) cells, this cell line is undeniably a workhorse for biopharmaceuticals production. Meanwhile, sialic acid terminals were reported to affect anti-inflammatory activity, antibody-dependent cellul...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cytotechnology |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Netherlands
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225233/ https://ncbi.nlm.nih.gov/pubmed/32125558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-020-00381-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|